Its encouraging the Promosalute are now taking measures to prepare for sales of Mente. They have opened the neurotechnology feedback centers (from memory) and now undertaking marketing to get doctors to start prescribing the device to patients. I get the impression that once the results come in (assuming they are positive), this will be the signicfiant catalyst for sales in Europe. FDA itself will not need to have occured.
Lets recall that it was Promosalute that originally sent the SP into a funk when they didn't deliver on their original distribution requirements. So their full engagement has the potential to get us back on track. The margins on this device are pretty compelling if sales start in earnest, we will be getting a well deserved re-rate.
NTI Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
